Skip to main content
. 2021 May 13;144(1):82–91. doi: 10.1111/acps.13309

TABLE 2.

Standardized 30‐Day Absolute Risks and average risk ratio for Composite of Death or Severe COVID‐19 in different subgroups of patients with psychiatric disorders

Composite outcome Total number of patients

Events

n (%)

30‐day absolute risk, % (95% CI) Standardized average risk ratio (95% CI)
No psychiatric disorders 127,281 1551 (1.2) 1.3 (1.2–1.4) Ref.
Schizophrenia spectrum disorders 984 48 (4.9) 3.1 (2.3–3.9) 2.43 (1.79–3.07)
Bipolar disorder 485 20 (4.1) 2.7 (1.6–3.8) 2.11 (1.25–2.97)
Unipolar depression 3764 102 (2.7) 2.2 (1.7–2.6) 1.70 (1.38–2.02)
Other psychiatric disorders 7328 73 (1.0) 1.4 (1.1–1.8) 1.13 (0.86–1.38)
Psychotropic drug redemption § 4479 242 (5.4) 2.1 (1.9–2.4) 1.70 (1.48–1.92)

COVID‐19, coronavirus disease 2019; CI, confidence interval.

Cox models included age, sex, highest obtained education, income, ischaemic heart disease, congestive heart failure, cerebrovascular disease, chronic kidney disease, hypertension, peripheral artery disease, diabetes, chronic obstructive pulmonary disorder, asthma, substance abuse and malignancy.

Patients without prior psychiatric diagnoses and who did not redeem psychotropic drugs within 90 days prior to index date.

§

Within 90 days prior to index date without having a hospital psychiatric diagnosis.